Wallis, R.M., Napier C.M., "Muscarinic Antagonists in development for disorders of smooth muscle function," Life-Sci., 64 (6-7), pp. 395-401. Abstract only. (1999). |
Choppin, A., Eglen, R.M., Hegde, S.S., "Pharmacological characterization of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle," Br. J. Pharmacol., vol. 124, pp. 883-888. Jul. 1998. Abstract only. |
Gillberg, P.G., Sundquist, S., Nilvebrant, L., "Comparison of the in vitro profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists," Eur. J. Pharmacol. (May 1998) vol. 349, pp. 285-292. |
Beaumont, K.C., Cussans, N.J., Nichols, D.J., Smith, D.A., "Pharmacokinetics and metabolism of darifenacin in the mouse, rat, dog and man," Xenobiotica, 28 (1), pp. 63-75. Abstract only. (Jan. 1998). |
Hegde, S.S., Choppin, A., Bonhaus, D., Briaud, S., Loeb, M., Moy, T.M., Loury, D., Eglen, R.M., "Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo," Br. J. Pharmacol., vol. 120 (8), pp. 1409-18. Abstract only. (Apr. 1997). |
Smith, C.M., Wallis, R.M., "Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors," J. Recpt. Signal-Transduct-Res., 17 (1-3), pp. 177-84. (May 1997). Abstract only. |
Alabaster, V.A., "Discovery & development of selective M3 antagonists for clinical use," Life-Sci., 60, pp. 1053-60. Abstract only. (1997). |
Kaye, B., Herron, W.J., P.V., Robinson, S., Stophe, D.A., Venn, R.F., Wild, W., "Rapid, solid phase extraction technique for the high-throughout assay of darifenacin in human plasma," Anal.Chem., 68(9), pp. 1658-60. (May 1996) Abstract only. |
H. Akiyama et al., "Morphological Diversities of CD44 Positive Astrocytes in The Cerebral Cortex of Normal Subjects and Patients with Alzheimer's Disease", Brain Research, 632:249-259 (1993). |
H. Tohgi et al., "Remarkable Reduction in Acetylcholine Concentration in the Cerebrospinal Fluid From Patients With Alzheimer Type Dementia", Neuroscience Letters, 177:139-142 (1994). |
J. Daly et al., "Adenosine Receptors in the Central Nervous System: Relationship to the Central Actions of Methylxanthines", Life Sciences, 28 (19) :2083-2097 (1981). |
M. Ballarin et al., "Extracellular Levels of Adenosine and its Metabolites in the Striatum of Awake Rats: Inhibition of Uptake and Metabolism", Acta Physiol Scand, 142:97-103 (1991). |
F. Parkinson et al., "Propentofylline: A Nuceloside Transport Inhibitor with Neuroprotective Effects in Cerebral Ischemia", Gen. Pharmac., 25 (6) :1053-1058 (1994). |
E. Messamore et al., "Astrocytes Associated with Senile Plaques Possess Muscarinic Acetylcholine Receptors", NeuroReport, 5 (12) :1473-1476 (Jul. 1994). |
Nitahara et al. Neuroscience, 67 (1), pp. 159-168. (Jul. 1995). |